Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AdventHealth
Age
18–90
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Age 18 - 90
Male or female
Eligible participants for this telesurgery study must have a clearly defined indication for robotic urologic surgery, specifically:
* Localized Prostate Cancer (ICD-10: C61), appropriate for robotic radical prostatectomy.
OR
Benign Prostate diseases appropriate for robotic simple prostatectomy (ICD-10: N40) These diagnoses are confirmed by clinical examination, imaging, and/or pathology prior to surgical planning. Patients with vague or unspecified urologic conditions will be excluded to ensure the safety and appropriateness of the surgical intervention.
Primary diagnosis of urinary system disease and prostate disorders (C61 and N40.1) scheduled to undergo treatment with robotic surgery. These patients don't have access to robotic surgery in their routine and the study will give them the opportunity to have advanced technology and the gold-standard treatment with experts in the field.
Willing to participate in the study
Mentally capable of comprehending the study protocol
You may not be if
Patients who, based on multidisciplinary evaluation (surgical, anesthetic, and medical), are deemed not suitable for robotic surgery due to high perioperative risk. This includes but is not limited to:
* Uncontrolled cardiovascular, pulmonary, or metabolic disease.
* Severe anesthetic risk classified as ASA Class IV or higher.
Patients enrolled in another interventional research study that may interfere with surgical safety or outcomes.
Patients unwilling or unable to comply with the perioperative and follow-up schedule.
Vulnerable populations are excluded from this study, including:
* Minors (under 18 years old)
* Prisoners
* Cognitively impaired or decisional incapacitated individuals
Clareo Health | Exploring the Potential of Robotic Telesurgery in Remote Settings
